{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-001429","form_type":"8-K","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.848085+00:00","generated_at":"2026-05-24T01:43:43.971706+00:00","sec_items":["1.01","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetVivo raises $5M in Series B convertible preferred stock financing","bullets":["Initial $600K received; investor may purchase remaining $4.4M by May 27, 2025.","Preferred shares pay 10% annual dividend in common stock; convertible 1:1 into common.","Company can call shares after 2 years at $1.15 per share; proceeds for commercialization.","Stock trades OTCQB (PETV) after Nasdaq delisting; offering is exempt under Section 4(a)(2).","Use of proceeds: lead products Spryng and PrecisePRP, clinical trials, working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-001429","json":"https://secwatch.observer/filing/0001641172-25-001429.json","markdown":"https://secwatch.observer/filing/0001641172-25-001429.md","text":"https://secwatch.observer/filing/0001641172-25-001429.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225001429/0001641172-25-001429-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000164117225001429/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:43:43.971706+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}